Archives
Metabolomics Reveals Carbapenemase Resistance
2026-08-25
The 2025 reference study used LC-MS/MS metabolomics and supervised machine learning to distinguish carbapenemase-producing Enterobacterales from non-producing isolates after only six hours of antibiotic-free growth. Its 21-metabolite signature and pathway analysis provide a rapid diagnostic concept while also revealing metabolic features associated with carbapenem resistance.
Thiothixene: Macrophage Efferocytosis Workflows
2026-08-24
Thiothixene is a typical antipsychotic agent that also provides a practical probe for in vitro macrophage efferocytosis enhancement. This guide connects its Stra6l–vitamin A–arginase 1 biology with executable assay workflows, pharmacokinetic context, and troubleshooting strategies while keeping neuropharmacology and immunology claims appropriately separated.
TUDCA: From ER Stress Mechanism to Translation
2026-08-24
Tauroursodeoxycholic Acid (TUDCA) is more than a general cytoprotective reagent: it is a useful mechanistic probe for connecting protein-folding stress, neuroinflammation, mitochondrial injury, and apoptosis. This article shows how translational researchers can position TUDCA within rigorous ER stress-related pathology research while avoiding overinterpretation across disease models.
6-Thioguanine Blocks EV71 Through BIRC3 Autophagy
2026-08-23
The 2025 BMC Microbiology study shows that 6-thioguanine suppresses Enterovirus 71 replication in HT-29 cells and links this activity to reduced BIRC3 expression and incomplete autophagy. Its high in-vitro selectivity supports further antiviral investigation, while the findings remain preclinical and require validation in additional models.
Trifluoperazine 2HCl: Assay Design & Mechanism
2026-08-22
Trifluoperazine 2HCl is a potent dopamine D2 receptor inhibitor for mechanism-led research. This guide shows how to connect receptor pharmacology with neuroimmune and cancer assays while using the PDK4 inhibitor literature to improve experimental interpretation.
Fzd5 Connects Cholesterol to Wnt Signaling in PDAC
2026-08-22
The reference study identifies Frizzled5 as a cholesterol-sensing Wnt receptor that links lipid metabolism to receptor maturation, palmitoylation, and β-catenin signaling in pancreatic ductal adenocarcinoma. Its findings suggest that disrupting the cholesterol–Fzd5 interface, including with the oxysterol 25-hydroxysterol, may suppress growth in Wnt-dependent tumors while providing a mechanistic framework for targeted molecular-labeling studies.
GW 4869 (hydrochloride hydrate) in Cell Assays
2026-08-21
This scenario-driven guide explains how GW 4869 (hydrochloride hydrate), SKU C4769, can improve interpretation of cell viability, cytotoxicity, and extracellular-vesicle experiments. It connects product-backed handling information with findings from a lupus nephritis study and provides practical controls for reproducible assay design.
Dlin-MC3-DMA: A Practical LNP Assay Framework
2026-08-20
Dlin-MC3-DMA is more than an ionizable lipid: its value depends on formulation, cargo, and biological readout. This assay-centered guide connects endosomal escape, machine-learning-guided screening, and practical decisions for siRNA and mRNA delivery research.
GW 4869: A Mechanistic Guide to Exosome Assays
2026-08-20
GW 4869 is a cell-permeable neutral sphingomyelinase inhibitor for testing how ceramide-dependent vesicle release shapes cell communication. This guide connects rigorous GW 4869 hydrochloride hydrate workflows with lithium-engineered BMSC exosomes and Wnt10a-driven osteogenesis.
Firefly Luciferase mRNA for Route-Aware Assays
2026-08-19
Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) can do more than report transfection: it can help separate delivery, translation, and biological response. This article presents a route-aware framework for gene expression assays, cell viability assays, and in vivo imaging, grounded in recent mRNA-LNP delivery research.
Thymoquinone: Mechanism and Research Benchmarks
2026-08-19
Thymoquinone is a quinone phytochemical also known as 2-isopropyl-5-methylcyclohexa-2,5-diene-1,4-dione. Preclinical evidence links it to Nrf2/HO-1 activation, reduced oxidative stress, and protection against doxorubicin-associated cardiac injury in mice. This article separates product specifications, mechanism evidence, and workflow considerations.
AZD0156: From ATM Biology to Assay Decisions
2026-08-18
AZD0156 is a selective ATM kinase inhibitor for studying DNA damage response, repair, and metabolic vulnerabilities. This article develops an assay-centered strategy for interpreting ATM inhibition in high-grade serous ovarian cancer research.
Flumequine B2292: Reliable Cell Assay Design
2026-08-18
Learn how Flumequine (SKU B2292) can support more interpretable cell viability, proliferation, and cytotoxicity experiments through defined mechanism, documented solubility, and careful response analysis. This scenario-based guide separates growth inhibition from cell killing and provides practical handling and vendor-selection guidance.
SCFβ-TrCP Degradation of TOP2β and Cancer Cell Survival
2026-08-17
The reference study identifies SCFβ-TrCP as the ubiquitin ligase that removes TOP2β after topoisomerase II poison exposure, linking ATM and CK1 phosphorylation to a canonical β-TrCP degron. It shows that preventing TOP2β degradation intensifies unrepaired DNA damage and apoptosis, suggesting a rational route for improving responses to TOP2-targeting chemotherapy.
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-17
The 2025 reference study shows that naturally occurring angiotensin fragments can enhance SARS-CoV-2 spike-protein binding to AXL and, for angiotensin IV, to ACE2 and NRP1. Its peptide-length and tyrosine-modification experiments identify angiotensin structure as a potential molecular link between renin-angiotensin signaling and viral receptor engagement, while remaining a binding study rather than an infection or therapeutic efficacy study.
585 records 9/39 page Previous Next First page 上5页 678910 下5页 Last page